David Laplaud

Microglial control of astrocytes in response to microbial metabolites

Veit Rothhammer, Davis Borucki, Emily Tjon et al. · Nature · 2018 · 1K citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Evidence for a two-stage disability progression in multiple sclerosis

Emmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page et al. · Brain · 2010 · 587 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations

Life Sciences, Neurology, Neuroscience +17

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Céline Louapre, Nicolas Collongues, Bruno Stankoff et al. · JAMA Neurology · 2020 · 466 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +14

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14